Literature DB >> 20512605

DFT investigation on the reaction mechanism catalyzed by α-phosphomannomutase1 in protonated/deprotonated states.

Hui-Ying Chu1, Qing-Chuan Zheng, Xue Li, Yong-Shan Zhao, Ji-Long Zhang, Hong-Xing Zhang.   

Abstract

Congenital disorder of glycosylation type 1a (CDG-1a) which is a congenital disease, is caused by mutations in α-Phosphomannomutase1. The reaction mechanism of the α-phosphomannomutase1 enzyme has been investigated by means of density functional theory using the hybrid functional B3LYP. The α-phosphomannomutase1 catalyzes the interconversion of the α-D-mannose 1-phosphate to D-mannose 6-phosphate via a mannose-1,6-(bis) phosphate intermediate. The quantum chemical models, which were chosen in protonated/deprotonated states models, were built on the basis of the docking result. The process of the phosphoryl group transferred from Asp19 to the mannose 6-phosphate is in different steps in the two states, but are both coupled with the protons transfer. Our computational results support the hypothesis that the Asp19 as a nucleophile plays an important role in the α-phosphomannomutase1 biology function, and indicate Gln62 could help to stabilize the phosphoryl group and the structure of the substrate. In addition, we can conjecture that the deprotonated state is more suitable for product release.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20512605     DOI: 10.1007/s00894-010-0743-3

Source DB:  PubMed          Journal:  J Mol Model        ISSN: 0948-5023            Impact factor:   1.810


  21 in total

1.  Functional analysis of novel mutations in a congenital disorder of glycosylation Ia patient with mixed Asian ancestry.

Authors:  V Westphal; G M Enns; M F McCracken; H H Freeze
Journal:  Mol Genet Metab       Date:  2001-05       Impact factor: 4.797

2.  Unexpected deacetylation mechanism suggested by a density functional theory QM/MM study of histone-deacetylase-like protein.

Authors:  Clémence Corminboeuf; Po Hu; Mark E Tuckerman; Yingkai Zhang
Journal:  J Am Chem Soc       Date:  2006-04-12       Impact factor: 15.419

3.  Kinetic mechanism and pH dependence of the kinetic parameters of Pseudomonas aeruginosa phosphomannomutase/phosphoglucomutase.

Authors:  L E Naught; P A Tipton
Journal:  Arch Biochem Biophys       Date:  2001-12-01       Impact factor: 4.013

Review 4.  Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency).

Authors:  H Carchon; E Van Schaftingen; G Matthijs; J Jaeken
Journal:  Biochim Biophys Acta       Date:  1999-10-08

5.  Kinetic properties and tissular distribution of mammalian phosphomannomutase isozymes.

Authors:  M Pirard; Y Achouri; J F Collet; E Schollen; G Matthijs; E Van Schaftingen
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

6.  Methyl transfer in glycine N-methyltransferase. A theoretical study.

Authors:  Polina Velichkova; Fahmi Himo
Journal:  J Phys Chem B       Date:  2005-04-28       Impact factor: 2.991

7.  The X-ray crystal structures of human alpha-phosphomannomutase 1 reveal the structural basis of congenital disorder of glycosylation type 1a.

Authors:  Nicholas R Silvaggi; Chunchun Zhang; Zhibing Lu; Jianying Dai; Debra Dunaway-Mariano; Karen N Allen
Journal:  J Biol Chem       Date:  2006-03-15       Impact factor: 5.157

8.  Phosphomannomutase deficiency is a cause of carbohydrate-deficient glycoprotein syndrome type I.

Authors:  E Van Schaftingen; J Jaeken
Journal:  FEBS Lett       Date:  1995-12-27       Impact factor: 4.124

9.  Intestinal, pancreatic and hepatic involvement in carbohydrate-deficient glycoprotein syndrome type I.

Authors:  B Kristiansson; S Borulf; N Conradi; C Erlanson-Albertsson; W Ryd; H Stibler
Journal:  J Pediatr Gastroenterol Nutr       Date:  1998-07       Impact factor: 2.839

Review 10.  Congenital disorders of glycosylation: have you encountered them?

Authors:  V Westphal; G Srikrishna; H H Freeze
Journal:  Genet Med       Date:  2000 Nov-Dec       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.